Generically known as sodium phosphate, or sodium biphosphate, Fleet Phospho-soda is a bowel cleansing medication prescribed to patients prior to endoscopy, surgery, x-rays or various other intestinal procedures. Fleet Phospho-soda comes in the form of a tablet, oral solution and rectal enema. In most cases, patients will have a limited or restricted diet while taking Fleet Phospho-soda in the 24 hours prior to undergoing their procedure.

Fleet Phospho-soda is produced by C.B. Fleet. Other brand names of sodium phosphate medications include OsmoPrep and Visicol, both produced by Salix Pharmaceuticals.

FDA Warns Consumers of Dangers

On Dec. 11, 2008, the U.S. Food and Drug Administration (FDA) mandated that C.B. Fleet include a "black box" warning—the most serious type of FDA warning—on all Fleet Phospho-soda packaging. Four days later, C.B. Fleet issued a voluntarily nationwide recall of Fleet Phospho-soda products.

Fleet Phospho-soda Side Effects

The most severe side effect of Fleet Phospho-soda is acute phosphate nephropathy, a life-threatening kidney condition in which the development of phosphate crystals on the kidneys causes serious tissue damage and, eventually, kidney failure. The earlier acute phosphate nephropathy is diagnosed, the better the chances of survival and recovery.

In most cases, this kidney disorder is treated with dialysis and/or kidney transplant. Symptoms of acute phosphate nephropathy include:

• Bloating
• Discomfort
• Epilepsy
• Fatigue
• Hypertension
• Irregular heartbeat
• Lower back pain
• Twitching and muscle cramping
• Urination problems

Fleet Phospho-soda patients who develop any of these symptoms should seek emergency medical attention to prevent possibly fatal complications. Tragically, most patients don't recognize the presence of acute phosphate nephropathy until the condition has progressed to acute renal failure. Such patients typically lose more than 75 percent of their kidney function prior to getting the proper medical care.

Fleet Phospho-soda Lawsuits & Settlements

Injured Fleet Phospho-soda patients should, once their health is stable, consult with a defective drug attorney to find out if they are eligible to seek compensation for the damages they incurred. Recoverable damages may include more than just physical injuries. They may also include financial losses such as medical expenses and lost wages, and emotional losses including pain and suffering.

To speak with a defective drug attorney at Gacovino, Lake and Associates, contact our offices today. We will discuss your specific circumstances, in full, to determine if we can help you.

• Accutane®
• Ambien Drug Information
• Avandia
• Chantix Drug Information
• Darvocet® Drug Information
• Darvon® Pulled from Market
• Denture Cream
• Digitek Drug Information
• Epilepsy Drugs
• Fleet Phospho-Soda
• Fosamax Drug Information
• Heparin Drug Information
• Hydroxycut Drug Information
• Ketek Drug Information
• Levaquin Drug Information
• Mirapex Drug Information
• MRI Contrast Dye
• Neurontin Drug Information
• Paxil Birth Defects
• Prempro Drug Information
• Prozac Drug Information
• Raptiva Drug Information
• Reglan Drug Information
• Remicade Drug Information
• Seroquel
• Strattera Drug Information
• Trasylol Drug Information
• Wellbutrin Drug Information
• Yaz Drug Information

News

• January 30, 2012
  8 Tips for Safe Use of an Electric Space Heater
• January 27, 2012
  10 Fireplace Safety Tips
• January 25, 2012
  Statins Found to Increase Risk of Diabetes in Postmenopausal Women
• January 23, 2012
  Risk of Serious Bleeding from Aspirin May Not Be Worth the Benefits
• January 20, 2012
  Investigators Find Most Hospital Errors Are Never Reported
• January 19, 2012
  Drug Error Alert: Over-the-Counter Drugs May Be Mixed with Prescriptions
• January 17, 2012
  Recommendations for Lowering Levels of Lead Poisoning Standards
• January 16, 2012
  FDA Ordering Risk Study for Implantable Surgical Mesh
• January 15, 2012
  4 Ways to Prevent an Overdose of Liquid Acetaminophen in Younger Children
• January 14, 2012
  FDA Questioned on Missing Data Concerning Safety of Silicone Breast Implants